Ampio granted IND for inhaled COVID-19 therapy
September 21, 2020 -- Ampio Pharmaceuticals has received Investigational New Drug (IND) authorization from the U.S. Food and Drug Administration, allowing it to conduct additional clinical trials to test Ampion inhalation therapy for patients with COVID-19.
City of Hope licenses CAR T therapy to Chimeric Therapeutics
September 21, 2020 -- City of Hope has licensed intellectual property for its chlorotoxin chimeric antigen receptor (CAR) T cell therapy to Chimeric Therapeutics.
Integral Molecular touts PA grant to advance COVID-19 research
September 21, 2020 -- Integral Molecular was awarded over $520,000 from the state of Pennsylvania to leverage its technologies in COVID-19 research. The grant will enable the company and its partners to develop therapies and vaccines against SARS-CoV-2.
PharmAbcine, Samsung Biologics expand partnership
September 21, 2020 -- PharmAbcine and Samsung Biologics have entered into a new strategic partnership for the development and manufacturing of PMC-403, a next-generation antibody therapeutic candidate to treat neovascular disorders.
Ufovax advances self-assembling nanoparticle COVID-19 vaccine
September 18, 2020 -- Vaccine biotechnology company Ufovax announced it will begin phase I clinical trials of its one-component, self-assembling protein nanoparticle (1c-SApNP) SARS-CoV-2 vaccine.
Axon Neuroscience to research COVID-19 vaccine
September 18, 2020 -- Clinical-stage biotechnology company Axon Neuroscience plans to start clinical trials of an independently developed, crowdfunded vaccine against COVID-19 called ACvac1.
DIY vaccines are a landmine of public health concerns
September 18, 2020 -- A new Science article describes the legal and ethical implications of do-it-yourself (DIY) COVID-19 vaccines.
Elicio, Moffitt to study combination CAR-T therapy
September 18, 2020 -- Elicio Therapeutics and the Moffitt Cancer Center have established a collaboration to study Elicio's amphiphile immunotherapies with CD19 chimeric antigen receptor-T (CAR-T) cells.
ImmunoPrecise, Zymeworks partner on SARS-CoV-2 antibody
September 17, 2020 -- ImmunoPrecise and Zymeworks have announced that they have formed a research collaboration to develop a multispecific SARS-CoV-2 antibody.
Amgen, Eli Lilly to scale up manufacturing of COVID-19 antibody therapies
September 17, 2020 -- Eli Lilly and Amgen will collaborate on global antibody manufacturing to significantly increase the supply capacity of Lilly's potential COVID-19 therapies.
ESMO Virtual Congress 2020
September 14-29
BioProcess International West
September 21-25
BioProcess International
September 21-25
ASGCT 2020 Policy Summit
September 23-25
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter